By Josh White
Date: Monday 12 May 2025
(Sharecast News) - Tristel announced on Monday that it has received FDA clearance to begin immediate sales of its ophthalmic disinfectant foam, Tristel OPH, in the United States.
The AIM-traded firm said the high-level disinfectant was approved for use on a range of reusable ophthalmic instruments, including tonometers, retinal imaging probes,...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news